We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Paroxetine

Paroxetine is a medication primarily used to treat several conditions, primarily related to mental health. Paroxetine is commonly prescribed for major depressive disorder (MDD). It helps alleviate symptoms such as persistent sadness, loss of interest in usual activities, changes in appetite or sleep patterns, and feelings of worthlessness.Paroxetine also help In Social Anxiety Disorder (SAD), Generalized Anxiety Disorder (GAD), Obsessive-Compulsive Disorder (OCD) and Panic Disorder

"Synchemia specializes in the supply of Paroxetine impurities that meet specific pharmacopeial standards (EP/BP/USP/IP), as well as process-related impurities. Paroxetine is a medication used to depressive disorder and Synchemia ensuring the purity and quality of its impurities that are crucial for pharmaceutical manufacturing companies for regulatory compliance."

download image Download catalogue

Pharmaceutical Reference Standards

Paroxetine Impurity 23
Paroxetine Impurity 23
CAT No SRC-P42718
CAS No 1257974-55-2
Mol.F. C9H10N2O2
Mol.Wt. 178.2g/mole
INV STATUS CUSTOM SYNTHESIS
black arrow Previous 1...34 Next black arrow

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.